Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development
Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by...
Gespeichert in:
Veröffentlicht in: | Drug development research 2004-06, Vol.62 (2), p.119-123 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 123 |
---|---|
container_issue | 2 |
container_start_page | 119 |
container_title | Drug development research |
container_volume | 62 |
creator | Gunther, Erik C. Gerwien, Robert W. |
description | Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ddr.10374 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17291280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17291280</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</originalsourceid><addsrcrecordid>eNp1kMtu1DAUQC0EEkNhwR94hcQi1HYejtlBh5ZWpaCKx9Jy7JvU4LFT25k2v8EXkyHAjtW9VzrnLg5Czyl5RQlhx8bEZSl59QBtKBFtwZgQD9GGMM6KqhT0MXqS0ndCKK3adoN-XkMKbso2eBx6rMG5yamIx5s52eDCMONuxgP4sLMaw_0YIaUDnOzgVZ4iYOWVW-D0Gr-N1gzWDzjfANbBZ_AZD2rEHeQ7AI-tx3ubY1gcsx77gE2cBmxgDy6Mu8V4ih71yiV49mceoS-n7z6fvC8uP56dn7y5LDQTTVW02oiW911HRF9SxbiqNeO0axqhO2iqGjrSKQKNIRXosq8FM7VipK16wbkuyyP0Yv07xnA7QcpyZ9MhgPIQpiQpZ4KylizgyxXUMaQUoZdjtDsVZ0mJPFSXS3X5u_rCHq_snXUw_x-U2-31X6NYDZsy3P8zVPwhG17yWn67OpMXn9rt1dcPp1KUvwA_kpcK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17291280</pqid></control><display><type>article</type><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gunther, Erik C. ; Gerwien, Robert W.</creator><creatorcontrib>Gunther, Erik C. ; Gerwien, Robert W.</creatorcontrib><description>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.10374</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>cellular physiology ; genomic expression signature analysis ; in vitro and in vivo drug development</subject><ispartof>Drug development research, 2004-06, Vol.62 (2), p.119-123</ispartof><rights>2004 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fddr.10374$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fddr.10374$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids></links><search><creatorcontrib>Gunther, Erik C.</creatorcontrib><creatorcontrib>Gerwien, Robert W.</creatorcontrib><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><title>Drug development research</title><addtitle>Drug Dev. Res</addtitle><description>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</description><subject>cellular physiology</subject><subject>genomic expression signature analysis</subject><subject>in vitro and in vivo drug development</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp1kMtu1DAUQC0EEkNhwR94hcQi1HYejtlBh5ZWpaCKx9Jy7JvU4LFT25k2v8EXkyHAjtW9VzrnLg5Czyl5RQlhx8bEZSl59QBtKBFtwZgQD9GGMM6KqhT0MXqS0ndCKK3adoN-XkMKbso2eBx6rMG5yamIx5s52eDCMONuxgP4sLMaw_0YIaUDnOzgVZ4iYOWVW-D0Gr-N1gzWDzjfANbBZ_AZD2rEHeQ7AI-tx3ubY1gcsx77gE2cBmxgDy6Mu8V4ih71yiV49mceoS-n7z6fvC8uP56dn7y5LDQTTVW02oiW911HRF9SxbiqNeO0axqhO2iqGjrSKQKNIRXosq8FM7VipK16wbkuyyP0Yv07xnA7QcpyZ9MhgPIQpiQpZ4KylizgyxXUMaQUoZdjtDsVZ0mJPFSXS3X5u_rCHq_snXUw_x-U2-31X6NYDZsy3P8zVPwhG17yWn67OpMXn9rt1dcPp1KUvwA_kpcK</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Gunther, Erik C.</creator><creator>Gerwien, Robert W.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200406</creationdate><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><author>Gunther, Erik C. ; Gerwien, Robert W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>cellular physiology</topic><topic>genomic expression signature analysis</topic><topic>in vitro and in vivo drug development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gunther, Erik C.</creatorcontrib><creatorcontrib>Gerwien, Robert W.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gunther, Erik C.</au><au>Gerwien, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev. Res</addtitle><date>2004-06</date><risdate>2004</risdate><volume>62</volume><issue>2</issue><spage>119</spage><epage>123</epage><pages>119-123</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><abstract>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/ddr.10374</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-4391 |
ispartof | Drug development research, 2004-06, Vol.62 (2), p.119-123 |
issn | 0272-4391 1098-2299 |
language | eng |
recordid | cdi_proquest_miscellaneous_17291280 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | cellular physiology genomic expression signature analysis in vitro and in vivo drug development |
title | Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T04%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolution%20of%20cellular%20physiology%20by%20genomic%20expression%20signature%20analysis:%20Bridging%20the%20content%20gap%20between%20in%20vitro%20and%20in%20vivo%20drug%20development&rft.jtitle=Drug%20development%20research&rft.au=Gunther,%20Erik%20C.&rft.date=2004-06&rft.volume=62&rft.issue=2&rft.spage=119&rft.epage=123&rft.pages=119-123&rft.issn=0272-4391&rft.eissn=1098-2299&rft_id=info:doi/10.1002/ddr.10374&rft_dat=%3Cproquest_cross%3E17291280%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17291280&rft_id=info:pmid/&rfr_iscdi=true |